Supplemental Content

Save items

Add to Favorites

loading

Related citations in PubMed

Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily. [Haematologica. 2011]
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily.
Krauth MT, Herndlhofer S, Schmook MT, Mitterbauer-Hohendanner G, Schlögl E, Valent P. Haematologica. 2011 Jan; 96(1):163-6. Epub 2010 Oct 7.

Review Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development. [Expert Opin Drug Saf. 2010]
Review Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.
Breccia M, Alimena G. Expert Opin Drug Saf. 2010 Sep; 9(5):713-21.

Review Pleural effusions due to dasatinib. [Curr Opin Pulm Med. 2010]
Review Pleural effusions due to dasatinib.
Brixey AG, Light RW. Curr Opin Pulm Med. 2010 Jul; 16(4):351-6.

Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy. [Int J Hematol. 2011]
Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy.
Kim D, Goh HG, Kim SH, Cho BS, Kim DW. Int J Hematol. 2011 Oct; 94(4):361-71. Epub 2011 Sep 8.

Review The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib. [J Hematol Oncol. 2009]
Review The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.
Masiello D, Gorospe G 3rd, Yang AS. J Hematol Oncol. 2009 Nov 12; 2:46. Epub 2009 Nov 12.

See reviews... See all...

Cited by 1 PubMed Central article

Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities. [Haematologica. 2011]
Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities.
Valent P. Haematologica. 2011 Oct; 96(10):1395-7.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.

Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.

Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Free in PMC
Free full text articles in PMC

Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Search details

21357709[uid]

See more...

Recent activity

Clear Turn Off Turn On

Pleural and pericardial effusions in chronic myeloid leukemia patients receiving...
Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.
Haematologica. 2011 Mar ;96(3):e15; author reply e16-7. doi: 10.3324/haematol.2011.040048.

PubMed

21357709[uid] (1)
PubMed

Your browsing activity is empty.
m=Eskazan%20AE%5BAuthor%5D&cauthor=true&cauthor_uid=21357709">Eskazan AE, Soysal T, Ongoren S, Gulturk E, Ferhanoglu B, Aydin Y.

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Search details

Recent activity

Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content